The Custodian Newspaper Online
No Result
View All Result
Friday, June 13, 2025
  • Home
  • News
  • Politics
  • Business
  • Opinion
  • Showbiz
  • Health
  • Sport
  • World
  • eStore
The Custodian Newspaper Online
  • Home
  • News
  • Politics
  • Business
  • Opinion
  • Showbiz
  • Health
  • Sport
  • World
  • eStore
No Result
View All Result
The Custodian Newspaper Online
No Result
View All Result
Home World

WHO Halts Hydroxychloroquine Trials Over Safety Fears

by John Kekeli
May 27, 2020
in World
0
WHO Halts Hydroxychloroquine Trials Over Safety Fears
152
SHARES
1.9k
VIEWS
Share on FacebookShare on Twitter

Testing of the malaria drug hydroxychloroquine as a possible treatment for coronavirus has been halted because of safety fears, the World Health Organization (WHO) has indicated.

Trials in several countries are being “temporarily” suspended as a precaution, the agency said on Monday.

It comes after a recent medical study suggested the drug could increase the risk of patients dying from Covid-19.

President Donald Trump has said he is taking the drug to ward off the virus.

The US president has repeatedly promoted the anti-malarial drug, against medical advice and despite warnings from public health officials that it could cause heart problems.

Last week, a study in medical journal The Lancet said there were no benefits to treating coronavirus patients with hydroxychloroquine, and that taking it might even increase the number of deaths among those in hospital with the disease.

Hydroxychloroquine is safe for malaria, and conditions like lupus or arthritis, but no clinical trials have recommended its use for treating Covid-19.

The WHO, which is running clinical trials of various drugs to assess which might be beneficial in treating the disease, has previously raised concerns over reports of individuals self-medicating and causing themselves serious harm.

On Monday, officials at the UN health agency said hydroxychloroquine would be removed from those trials pending a safety assessment.

The Lancet study involved 96,000 coronavirus patients, nearly 15,000 of whom were given hydroxychloroquine – or a related form chloroquine – either alone or with an antibiotic.

The study found that the patients were more likely to die in hospital and develop heart rhythm complications than other Covid patients in a comparison group.

The death rates of the treated groups were: hydroxychloroquine 18%; chloroquine 16.4%; control group 9%.

Those treated with hydroxychloroquine or chloroquine in combination with antibiotics had an even higher death rate.

The researchers warned that hydroxychloroquine should not be used outside of clinical trials.

Post Views: 395
  • Latest
  • Trending
N/R: Regional Director of Education urges BECE candidates to approach examination with confidence

N/R: Regional Director of Education urges BECE candidates to approach examination with confidence

June 12, 2025
Zoomlion, YEAz, contract

Govt terminates contract between Zoomlion and YEA

June 12, 2025
NCA, shuts down, Asaase radio,Wontumi FM,

NCA shuts down 62 radio stations

June 12, 2025
South Africa, floods,

Nearly 50 people killed in South Africa floods

June 12, 2025
Newspaper Frontpages (Wednesday, 11th June, 2025)

Newspaper Frontpages (Wednesday, 11th June, 2025)

June 11, 2025
Dumsor,fuel, levy,robbery,Minority,NPP,

GH¢1 ‘dumsor levy is midnight robbery’ — Minority declares

June 10, 2025
Cedi,weakens,dollar,

Cedi weakens against dollar

June 10, 2025
Sammy Gyamfi,Goldbod,economic,recovery,Mahama,

GoldBod to boost economic recovery agenda – Sammy Gyamfi

June 10, 2025

The CustodianGh Online’s vision is to become the most preferred go-to news brand in Ghana.

Contact Us

[email protected]

Popular Categories

  • News
  • Business
  • Politics
  • Sport
  • Arts & Showbiz
  • Tech

Archives

© 2025 The CustodianGh Online - All rights reserved.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT
No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • Opinion
  • Showbiz
  • Health
  • Sport
  • eStore

© 2025 The CustodianGh Online - All rights reserved.